Page last updated: 2024-08-26

moexipril and Hypertrophy, Left Ventricular

moexipril has been researched along with Hypertrophy, Left Ventricular in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Spinar, J; Vítovec, J	1
Bakhmet'eva, TA; Karpov, RS; Pavliukova, EN; Puzyrev, KV	1
Chrysant, GS; Nguyen, PK	1
Asmar, R; Goujoun, B; Hlawaty, M; Jourde, M; Maldonado, J; Olszowska, M; Sayegh, F; Tracz, W; Vincent, M	1

Reviews

1 review(s) available for moexipril and Hypertrophy, Left Ventricular

Article	Year
Moexipril and left ventricular hypertrophy. Vascular health and risk management, 2007, Volume: 3, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Humans; Hypertrophy, Left Ventricular; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Remodeling	2007

Trials

1 trial(s) available for moexipril and Hypertrophy, Left Ventricular

Article	Year
MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial. International journal of cardiology, 2005, Apr-20, Volume: 100, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Practice Guidelines as Topic; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines	2005

Article

Year

MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial.

International journal of cardiology, 2005, Apr-20, Volume: 100, Issue:2

Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Practice Guidelines as Topic; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines

2005

Other Studies

2 other study(ies) available for moexipril and Hypertrophy, Left Ventricular

Article	Year
[Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril]. Kardiologiia, 2006, Volume: 46, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Severity of Illness Index; Tetrahydroisoquinolines; Treatment Outcome	2006
Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension. Acta cardiologica, 2002, Volume: 57, Issue:1 Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Middle Aged; Tetrahydroisoquinolines; Ultrasonography	2002

Article

Year

[Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril].

Kardiologiia, 2006, Volume: 46, Issue:9

Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Severity of Illness Index; Tetrahydroisoquinolines; Treatment Outcome

2006

Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.

Acta cardiologica, 2002, Volume: 57, Issue:1

Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Middle Aged; Tetrahydroisoquinolines; Ultrasonography

2002